Company: NIVFW
Filing Date: 2025-08-22
Form Type: DRS
Source: 0001213900-25-079717
Chunk: 91

Company: NewGenIvf Group Ltd
Filing Date: 2025-08-22
Form: DRS
Chunk 91
---
vf’s reputation,
evolve into litigation, or otherwise have a material adverse impact on NewGenIvf’s reputation and business. Such proceedings might
result in substantial costs, regardless of the outcome, and may significantly divert management’s attention and resources from operating
NewGenIvf’s business, which might seriously harm its business, financial condition and results of operations. Insurance might not
cover such claims, might not provide sufficient payments to cover all the costs to resolve one or more such claims, and might not continue
to be available on terms acceptable to it. A claim brought against it that is uninsured or underinsured could result in unanticipated
costs, potentially harming its business, financial condition and results of operations. The outcomes of actions NewGenIvf institutes may
not be successful or favorable to NewGenIvf. Lawsuits against NewGenIvf may also generate negative publicity that significantly harms
NewGenIvf’s reputation, which may adversely affect NewGenIvf’s client base. NewGenIvf may also need to pay damages or settle
lawsuits with a substantial amount of cash.

<div align='center'>49</div>

Acquisitions, strategic investments, partnerships, or alliances could be difficult to identify, pose integration challenges, divert the attention of management, disrupt NewGenIvf’s business, dilute stockholder value, and adversely affect its business, financial condition and results of operations.

NewGenIvf may in the future
seek to acquire or invest in businesses, joint ventures, products and services, or technologies that it believes could complement or expand
its platform, enhance its technical capabilities, or otherwise offer growth opportunities. Any such acquisition or investment may divert
the attention of management and cause NewGenIvf to incur various expenses in identifying, investigating and pursuing suitable opportunities,
whether or not the transactions are completed, and may result in unforeseen operating difficulties and expenditures. In particular, NewGenIvf
may encounter difficulties assimilating or integrating the businesses, technologies, products and services, personnel or operations of
the acquired companies, particularly if the key personnel of the acquired company choose not to work for it, they are operationally difficult
to integrate, or NewGenIvf has difficulty retaining the clients of any acquired business due to changes in ownership, management or otherwise.
These transactions may also disrupt its business, divert its resources, and require significant management attention that would otherwise
be available for development of its existing business and may not benefit NewGenIvf’s business strategy, may not generate